Wanebo H J, Gaker D L, Whitehill R, Morgan R F, Constable W C
Ann Surg. 1987 May;205(5):482-95. doi: 10.1097/00000658-198705000-00006.
Pelvic recurrence is an ominous event after curative resection of rectal cancer and is rarely amenable to re-resection by conventional methods. A method to permit a composite resection of these using the abdominal sacral approach has been described previously. This report updates that experience with resection of pelvic recurrence of rectal cancer in 28 patients. Of these, 24 were done with curative intent, and four were done for palliation (mainly for infected or fungating tumor). All patients had extensive preoperative evaluation by clinical and radiologic tests, and most patients had a long free interval period of approximately 18 months, after their primary resection. Although 47 patients had exploratory surgery, only 29 had local disease amenable to resection and four had palliative resections. About half the patients had had an abdominoperineal resection, half had had an anterior resection, and one third had had previous efforts to resect the recurrence. All but one patient had been irradiated with 3000-11,000 cGy. All but two patients (of the 24 curative efforts) required a formal abdominosacral resection (through S1-2 in 12, S2-3 in 9, and S4-5 in 1). Over half the patients also required a bladder resection. There were three operative deaths (12%); one patient had a cardiac death immediately after operation and two were septic deaths at 35 and 60 days. The survivors generally had relief of sacral root pain and good motor function; most of those previously employed could return to work. The actuarial 5-year survival rate is 25% and median survival is 36 months. Long-term survival over 48 months was recorded in five of 21 surgical survivors (23.8%). Survival in a historic comparative group of 30 patients treated for local recurrence only (mainly by radiation) was 15 months median, and at 5 years the survival rate was 3% (p less than 0.001). In conclusion, selected patients with pelvic recurrence of rectal cancer may be retrieved by and returned to functional life with the composite abdominosacral resection.
盆腔复发是直肠癌根治性切除术后的不良事件,采用传统方法很少能再次切除。先前已描述了一种使用腹骶入路对这些病变进行联合切除的方法。本报告更新了28例直肠癌盆腔复发患者的切除经验。其中,24例手术目的为根治,4例为姑息性手术(主要针对感染或呈蕈状生长的肿瘤)。所有患者术前行广泛的临床和影像学检查评估,大多数患者在初次切除后有长达约18个月的无瘤间期。尽管47例患者接受了探查性手术,但仅29例患者的局部病变适合切除,4例患者接受了姑息性切除。约一半患者曾接受腹会阴联合切除术,一半患者曾接受前切除术,三分之一患者此前曾尝试切除复发病变。除1例患者外,所有患者均接受了3000 - 11,000 cGy的放疗。除2例患者(在24例根治性手术中)外,所有患者均需要进行正式的腹骶切除术(12例经S1 - 2,9例经S2 - 3,1例经S4 - 5)。超过一半的患者还需要进行膀胱切除。有3例手术死亡(12%);1例患者术后立即死于心脏疾病,2例患者分别于术后35天和60天死于败血症。幸存者骶神经根疼痛通常缓解,运动功能良好;大多数之前有工作的患者能够重返工作岗位。精算5年生存率为25%,中位生存期为36个月。21例手术幸存者中有5例(23.8%)记录到生存期超过48个月。在一个仅接受局部复发治疗(主要为放疗)的30例患者的历史对照队列中,中位生存期为15个月,5年生存率为3%(p < 0.001)。总之,部分直肠癌盆腔复发患者可通过腹骶联合切除术挽救,并恢复有功能的生活。